The effect of median and paramedian approach on post-dural puncture headache

Comparison of median versus paramedian approach effect on post-dural puncture headache under spinal anesthesia in the elective cesarean section

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170516033992N5

Enrollment

140

Registered

2020-12-26

Start date

2020-02-20

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Dural Puncture Headache. Other headache syndromes

Interventions

Intervention 1: Intervention group: group 1: Spinal anesthesia was conducted in the lumbar intervertebral space 4 and 5 with a 25g Quincke needle and 12 mg Marcaine 0.5 % (Marcain® made by Cobel comp

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women candidate for elective cesarean section Patients with ASA I and ASA II Cesarean section by spinal anesthesia

Exclusion criteria

Exclusion criteria: Patients with a history of migraine Patients with indication for emergency cesarean section Patients with previous history of headache after dural-puncture

Design outcomes

Primary

Measure	Time frame
Post-Dural Puncture Headache. Timepoint: In recovery room, ward , time of discharge and up to seven days after surgery. Method of measurement: Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
Nausea. Timepoint: Three times after surgery in recovery, ward and discharge time. Method of measurement: Interview with patient.;Vomiting. Timepoint: Three times after surgery in recovery, ward and discharge time. Method of measurement: Interview with patient.;Taking Ephedrine (milligram). Timepoint: Recovery. Method of measurement: Milligram.;Taking atropine. Timepoint: Recovery room. Method of measurement: Milligram.;Anesthetic dermatome. Timepoint: Once after surgery. Method of measurement: Clinical examination.	—

Measure

Time frame

Nausea. Timepoint: Three times after surgery in recovery, ward and discharge time. Method of measurement: Interview with patient.;Vomiting. Timepoint: Three times after surgery in recovery, ward and discharge time. Method of measurement: Interview with patient.;Taking Ephedrine (milligram). Timepoint: Recovery. Method of measurement: Milligram.;Taking atropine. Timepoint: Recovery room. Method of measurement: Milligram.;Anesthetic dermatome. Timepoint: Once after surgery. Method of measurement: Clinical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Tohid Karami

Oroumia University of Medical Sciences

karami.t@umsu.ac.ir+98 44 3198 8293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026